Ghassan B Hamra1, Kristen Lyall2, Gayle C Windham3, Antonia M Calafat4, Andreas Sjödin4, Heather Volk5, Lisa A Croen6. 1. From the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 2. AJ Drexel Autism Institute, Drexel University, Philadelphia, PA. 3. Division of Environmental and Occupational Disease Control, California Department of Public Health, Richmond, CA. 4. National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA. 5. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 6. Division of Research, Kaiser Permanente, Oakland, CA.
Abstract
BACKGROUND: Exposure to endocrine disruptors is unavoidable. Many such compounds are suspected to impact neurologic development of children, but most studies conducted have considered effects of individual chemicals in isolation. Because exposures co-occur, it is important to consider their health impacts in a single regression framework. METHODS: We applied Bayesian statistical tools (including shared mean and mixture priors for 25 unique chemicals) to study independent associations of endocrine disruptor biomarkers with autism spectrum disorder (ASD) (n = 491) and intellectual disability (n = 155), compared with 373 general population controls, in the Early Markers for Autism study. We measured biomarkers in maternal serum collected and stored from midpregnancy and considered them individually or as a class (i.e., summed polychlorinated biphenyls). We adjusted all models for original matching factors (child sex and month and year of birth), maternal age, maternal race/ethnicity, parity, and maternal education at the time samples were collected. We estimated the change in the odds of ASD or intellectual disability per 1 SD increase in the z-score of measured biomarker concentration for each chemical. RESULTS: Odds of ASD and intellectual disability did not change with increasing concentration for any specific endocrine disruptor. The effect estimates for each chemical were centered on or near an odds ratio of 1.00 in both models where we applied a shared mean or a mixture prior. CONCLUSION: Our mixtures analyses do not suggest an independent relationship with ASD or intellectual disability with any of the 25 chemicals examined together in this mixtures analysis.
BACKGROUND: Exposure to endocrine disruptors is unavoidable. Many such compounds are suspected to impact neurologic development of children, but most studies conducted have considered effects of individual chemicals in isolation. Because exposures co-occur, it is important to consider their health impacts in a single regression framework. METHODS: We applied Bayesian statistical tools (including shared mean and mixture priors for 25 unique chemicals) to study independent associations of endocrine disruptor biomarkers with autism spectrum disorder (ASD) (n = 491) and intellectual disability (n = 155), compared with 373 general population controls, in the Early Markers for Autism study. We measured biomarkers in maternal serum collected and stored from midpregnancy and considered them individually or as a class (i.e., summed polychlorinated biphenyls). We adjusted all models for original matching factors (child sex and month and year of birth), maternal age, maternal race/ethnicity, parity, and maternal education at the time samples were collected. We estimated the change in the odds of ASD or intellectual disability per 1 SD increase in the z-score of measured biomarker concentration for each chemical. RESULTS: Odds of ASD and intellectual disability did not change with increasing concentration for any specific endocrine disruptor. The effect estimates for each chemical were centered on or near an odds ratio of 1.00 in both models where we applied a shared mean or a mixture prior. CONCLUSION: Our mixtures analyses do not suggest an independent relationship with ASD or intellectual disability with any of the 25 chemicals examined together in this mixtures analysis.
Authors: Mireia Gascon; Martine Vrijheid; David Martínez; Joan Forns; Joan O Grimalt; Maties Torrent; Jordi Sunyer Journal: Environ Int Date: 2011-01-14 Impact factor: 9.621
Authors: Kristen Lyall; Vincent M Yau; Robin Hansen; Martin Kharrazi; Cathleen K Yoshida; Antonia M Calafat; Gayle Windham; Lisa A Croen Journal: Environ Health Perspect Date: 2018-01-02 Impact factor: 9.031
Authors: Jay H Lubin; Joanne S Colt; David Camann; Scott Davis; James R Cerhan; Richard K Severson; Leslie Bernstein; Patricia Hartge Journal: Environ Health Perspect Date: 2004-12 Impact factor: 9.031
Authors: Paul W Stewart; Edward Lonky; Jacqueline Reihman; James Pagano; Brooks B Gump; Thomas Darvill Journal: Environ Health Perspect Date: 2008-05-28 Impact factor: 9.031
Authors: Ann M Vuong; Changchun Xie; Roman Jandarov; Kim N Dietrich; Hongmei Zhang; Andreas Sjödin; Antonia M Calafat; Bruce P Lanphear; Lawrence McCandless; Joseph M Braun; Kimberly Yolton; Aimin Chen Journal: Int J Hyg Environ Health Date: 2020-06-07 Impact factor: 5.840
Authors: Kristen Lyall; Jennifer L Ames; Michelle Pearl; Michela Traglia; Lauren A Weiss; Gayle C Windham; Martin Kharrazi; Cathleen K Yoshida; Robert Yolken; Heather E Volk; Paul Ashwood; Judy Van de Water; Lisa A Croen Journal: Mol Autism Date: 2021-03-18 Impact factor: 7.509
Authors: Ghassan B Hamra; Richard F Maclehose; Lisa Croen; Elizabeth M Kauffman; Craig Newschaffer Journal: Int J Environ Res Public Health Date: 2021-02-03 Impact factor: 3.390
Authors: Emily E Joyce; Jorge E Chavarro; Juliette Rando; Ashley Y Song; Lisa A Croen; M Daniele Fallin; Irva Hertz-Picciotto; Rebecca J Schmidt; Heather Volk; Craig J Newschaffer; Kristen Lyall Journal: Autism Res Date: 2022-03-08 Impact factor: 4.633
Authors: Judit Biosca-Brull; Cristian Pérez-Fernández; Santiago Mora; Beatriz Carrillo; Helena Pinos; Nelida Maria Conejo; Paloma Collado; Jorge L Arias; Fernando Martín-Sánchez; Fernando Sánchez-Santed; Maria Teresa Colomina Journal: Int J Environ Res Public Health Date: 2021-05-13 Impact factor: 3.390